Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of British Columbia

$845,326.00

Understanding mutagenic replication-transcription conflicts in cancer-initiation

FY 2017-18

Summary
Mutations in DNA are a driving force in cancer initiation, progression and therapy resistance. Some mutations arise from normal functions involving DNA. These functions include copying DNA during cell division, and transcribing DNA into RNA messages that control the production of proteins in the cell. These two independent processes, termed DNA replication and transcription, must occur at the same time on the same DNA, and therefore they can interfere with one another. We now know that these replication-transcription conflicts are a potential source of DNA damage and mutations and are thought to be influenced by breast cancer susceptibility genes. This proposal will clearly define new roles for breast cancer tumour suppressor genes in preventing replication-transcription conflicts, and survey the prevalence of such conflicts in normal cells from individuals with elevated 5-year risk for breast cancer and in early and late stage breast cancer samples. Our hope is to find new ways to selectively eliminate breast cancer cells experiencing high levels of replication-transcription collisions.
Program
Project Grant
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
379690
Name
Stirling Peter C
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Genetics
Theme2
Biomedical
Prcname2
Molecular & Cellular Biology of Cancer
Projecttitle
Understanding mutagenic replication-transcription conflicts in cancer-initiation
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$845,326
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cancer Susceptibility; Dna Damage; Dna Repair; Dna Replication; R-Loops; Replication Stress; Transcription; Tumour Suppressor Genes
Abstract
Mutations in DNA are a driving force in cancer initiation, progression and therapy resistance. Some mutations arise from normal functions involving DNA. These functions include copying DNA during cell division, and transcribing DNA into RNA messages that control the production of proteins in the cell. These two independent processes, termed DNA replication and transcription, must occur at the same time on the same DNA, and therefore they can interfere with one another. We now know that these replication-transcription conflicts are a potential source of DNA damage and mutations and are thought to be influenced by breast cancer susceptibility genes. This proposal will clearly define new roles for breast cancer tumour suppressor genes in preventing replication-transcription conflicts, and survey the prevalence of such conflicts in normal cells from individuals with elevated 5-year risk for breast cancer and in early and late stage breast cancer samples. Our hope is to find new ways to selectively eliminate breast cancer cells experiencing high levels of replication-transcription collisions.
Competitiondate
201803
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Stirling, Peter C
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $845,326~ $0~